Medicines / Cadila Pharmaceuticals / Sneezy
SneezyParacetamol + Phenylpropanolamine + Chlorpheniramine
Sneezy is marketed by Cadila Pharmaceuticals. 4 packs on NPPA's price list for July 2026, containing Paracetamol + Phenylpropanolamine + Chlorpheniramine.
- Packs listed
- 4
- Lowest MRP
- ₹11.25
- Per unit
- ₹0.21 to ₹4.49
- Price-controlled packs
- 0 of 4
- Dosage forms
- 3
Packs and prices
- ₹69.75Sneezy 125/12.5/1 mg Suspension 60 mlParacetamol + Phenylpropanolamine + Chlorpheniramine Suspension 125/12.5/1 mg · ₹1.16 per ml
- ₹12.38Sneezy New 125/5/1 mg Syrup 60 mlParacetamol + Phenylpropanolamine + Chlorpheniramine Syrup 125/5/1 mg · ₹0.21 per ml
- ₹11.25Sneezy New 325/5/2 mg Tablet 10Paracetamol + Phenylpropanolamine + Chlorpheniramine Tablet 325/5/2 mg · ₹1.13 per tablet
- ₹44.86Sneezy 500/25/2 mg Tablet 10Paracetamol + Phenylpropanolamine + Chlorpheniramine Tablet 500/25/2 mg · ₹4.49 per tablet
The company
Cadila Pharmaceuticals has 974 packs on the price list, and CDSCO has named it as the manufacturer of 21 failed batches since Mar 2017. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.